These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37760635)

  • 1. Identification of Potentially Novel Molecular Targets of Endometrial Cancer Using a Non-Biased Proteomic Approach.
    Taylor AH; Konje JC; Ayakannu T
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation.
    Maxwell GL; Hood BL; Day R; Chandran U; Kirchner D; Kolli VS; Bateman NW; Allard J; Miller C; Sun M; Flint MS; Zahn C; Oliver J; Banerjee S; Litzi T; Parwani A; Sandburg G; Rose S; Becich MJ; Berchuck A; Kohn E; Risinger JI; Conrads TP
    Gynecol Oncol; 2011 Jun; 121(3):586-94. PubMed ID: 21458040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the proteomic signature of human endometrial receptivity.
    Garrido-Gómez T; Quiñonero A; Antúnez O; Díaz-Gimeno P; Bellver J; Simón C; Domínguez F
    Hum Reprod; 2014 Sep; 29(9):1957-67. PubMed ID: 25106620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic identification of PKM2 and HSPA5 as potential biomarkers for predicting high-risk endometrial carcinoma.
    Teng Y; Ai Z; Wang Y; Wang J; Luo L
    J Obstet Gynaecol Res; 2013 Jan; 39(1):317-25. PubMed ID: 22889453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.
    Martinez-Garcia E; Lesur A; Devis L; Cabrera S; Matias-Guiu X; Hirschfeld M; Asberger J; van Oostrum J; Casares de Cal MLÁ; Gómez-Tato A; Reventos J; Domon B; Colas E; Gil-Moreno A
    Clin Cancer Res; 2017 Nov; 23(21):6458-6467. PubMed ID: 28790116
    [No Abstract]   [Full Text] [Related]  

  • 7. Proteomic Analysis of Endometrial Cancer Tissues from Patients with Type 2 Diabetes Mellitus.
    Mujammami M; Rafiullah M; Alfadda AA; Akkour K; Alanazi IO; Masood A; Musambil M; Alhalal H; Arafah M; Rahman AMA; Benabdelkamel H
    Life (Basel); 2022 Mar; 12(4):. PubMed ID: 35454982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis.
    Liu J; Nie S; Liang J; Jiang Y; Wan Y; Zhou S; Cheng W
    J Cell Biochem; 2019 Sep; 120(9):15648-15660. PubMed ID: 31056798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components.
    Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
    Hum Reprod; 2018 Mar; 33(3):399-410. PubMed ID: 29309596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DJ-1 in endometrial cancer: a possible biomarker to improve differential diagnosis between subtypes.
    Morelli M; Scumaci D; Di Cello A; Venturella R; Donato G; Faniello MC; Quaresima B; Cuda G; Zullo F; Costanzo F
    Int J Gynecol Cancer; 2014 May; 24(4):649-58. PubMed ID: 24614826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
    Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
    Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive serum proteomic analysis in early endometrial cancer.
    Uyar DS; Huang YW; Chesnik MA; Doan NB; Mirza SP
    J Proteomics; 2021 Mar; 234():104099. PubMed ID: 33412313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential proteomic analysis of endometrial fluid suggests increased inflammation and impaired glucose metabolism in non-implantative IVF cycles and pinpoints PYGB as a putative implantation marker.
    Azkargorta M; Escobes I; Iloro I; Osinalde N; Corral B; Ibañez-Perez J; Exposito A; Prieto B; Elortza F; Matorras R
    Hum Reprod; 2018 Oct; 33(10):1898-1906. PubMed ID: 30169642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel molecular profiles of endometrial cancer-new light through old windows.
    Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
    Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
    J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic sift through serum and endometrium profiles unraveled signature proteins associated with subdued fertility and dampened endometrial receptivity in women with polycystic ovary syndrome.
    Rashid N; Nigam A; Jain SK; Naqvi SH; Wajid S
    Cell Tissue Res; 2020 Jun; 380(3):593-614. PubMed ID: 32052139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-Based Proteomic Profiling in Patients with Hyperplasia and Endometrial Cancer.
    Akkour K; Alanazi IO; Alfadda AA; Alhalal H; Masood A; Musambil M; Rahman AMA; Alwehaibi MA; Arafah M; Bassi A; Benabdelkamel H
    Cells; 2022 Jul; 11(13):. PubMed ID: 35805203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of laminin-1 and matrix metalloproteinase-9 in benign and malignant endometrium.
    Küçükaydın Z; Başaran M; Ünlü Y; Başaran A; Kurdoğlu M
    Turk J Med Sci; 2023 Feb; 53(1):149-159. PubMed ID: 36945954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
    Alkushi A; Köbel M; Kalloger SE; Gilks CB
    Int J Gynecol Pathol; 2010 Jul; 29(4):343-50. PubMed ID: 20567148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.